33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
18.38%
Net income growth above 1.5x BRZE's 4.11%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
13.65%
Less D&A growth vs. BRZE's 33.50%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
-9.57%
Both cut yoy SBC, with BRZE at -18.78%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-321.58%
Both reduce yoy usage, with BRZE at -47.88%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
29.43%
AR growth while BRZE is negative at -202.13%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-4339.78%
Negative yoy inventory while BRZE is 107.94%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
17.49%
Lower AP growth vs. BRZE's 700.00%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
-199.24%
Negative yoy usage while BRZE is 656.62%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
48.95%
Well above BRZE's 9.54%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-20.97%
Both yoy CFO lines are negative, with BRZE at -21.01%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
21.29%
Some CapEx rise while BRZE is negative at -42.09%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.55%
We have mild expansions while BRZE is negative at -89.90%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-46.58%
We cut debt repayment yoy while BRZE is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Buyback growth of 100.00% while BRZE is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.